The company's purpose is to conduct research, development, design, further processing, transformation, manufacture, marketing, sale, purchase, licensing, distribution, transportation, import and export of pharmaceutical products, artificial radioelements and all other similar products, of radioactive isotopes for industrial and medical applications, as well as of all kinds of medical, chemical, serological, pharmaceutical, industrial and electronic systems and software, including related products, devices, accessories and spare and replacement parts, and to provide services for itself and third parties of any kind in this context, including technical assistance, installation, maintenance and repair as well as training and education. The company may acquire, manage and transfer patents, trademarks and technical and industrial know-how, acquire, manage and sell real estate in Switzerland and abroad, participate in other companies in Switzerland and abroad, and establish branches and subsidiaries in Switzerland and abroad. The company may participate in group financing, in particular by granting loans to its direct or indirect shareholders or other group companies or providing guarantees or other securities of any kind for their liabilities to third parties, even if these loans or securities are in the exclusive interest of its direct or indirect shareholders or other group companies and are granted free of charge. The company is authorized to take financing, restructuring and intercession measures in favor of third parties, as well as to grant loans to third parties or provide securities for their obligations. The company is entitled to conduct all business and take all measures that are connected with the purpose of the company or appear to be directly or indirectly beneficial to it.